The 4-week prevalence of somatoform disorders and associated psychosocial impairment;4-Wochen-prävalenz somatoformer störungen und assoziierte psychosoziale beeinträchtigung

Nervenarzt

Volumn 74, Issue 3, 2003, Pages 245-251

  Schoepf, D ^a   Heun, R ^a   Weiffenbach, O ^a   Herrmann, S ^a   Maier, W ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

4 week prevalence of somatoform disorders; Associated psychosocial impairment; Male female differences; Primary care setting in western Germany; Psychosocial stress factors

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GERMANY; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; NEURASTHENIA; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHOGENIC PAIN; PSYCHOSOCIAL DISORDER; SEX DIFFERENCE; SOCIAL PROBLEM; SOMATIZATION; SOMATOFORM DISORDER;

ADOLESCENT; ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; HYPOCHONDRIASIS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MENTAL DISORDERS; MIDDLE AGED; NEURASTHENIA; PRIMARY HEALTH CARE; PSYCHOPHYSIOLOGIC DISORDERS; RISK FACTORS; SEX FACTORS; SOCIAL ADJUSTMENT; SOMATOFORM DISORDERS; WORLD HEALTH ORGANIZATION;

EID: 0037599498     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-001-1241-8     Document Type: Article

References (43)

1. Bass CM, Murphy M (1995) Somatoform and personality disorders. Syndromal comorbidity and overlapping developemental pathways. Psychosom Res 39: 403-427
2. Barsky JA, Barnett MC, Clearyy PD (1994) Hypochondriasis and Panic Disorder. Boundary and Overlap. Arch Gen Psychiatry 51: 918-925
3. Bland M (1987) An introduction to medical statistics. Med Public, Oxford
4. Bridges KW, Goldberg DP (1985) Somatic presentation of DSM-III psychiatric disorders in primary care. J Psychos Res 29: S63-569
5. Cloninger CR, Sigvardsson S, von Knorring AL, Bohmann M (1988) An adoption study of somatoform disorders. Arch Gen Psychiat 41: 863-871
6. Colton T (1974) Statistics in Medicine. Little Brown, Boston
7. Davies OL, Goldsmith PL (1972) Statistical methods in research and production. Oliver and Boyd, Edingburgh
8. Dilling H, Mombour W, Schmidt MH, Schulte-Markwort E (1994) Internationale Klassifikation psychischer Störungen, ICD 10, Kapitel V (F). Forschungskriterien. Huber, Bern
9. Escobar JI, Rubio Stipec M, Gannio, Karno GM (1989) Somatic symptom index (SSI) a new and abriged somatisation construct. Prevalence and epidemiological correlates in two large community samples. J Nerv Ment Dis 177: 140-146
10. Fink P (1992) The use of hospitalisations by persistent somatizing patients. Psychol Med 22: 173-180
11. Franz M, Schellberg D, Schepank H (1995) Indikatoren und Einflußfaktoren des Langzeitspontanverlaufs psychogener Erkrankungen. Psychother Psychosom Med Psychol 45: 41-51
12. Freyberger H, Freyberger HJ (1994) Supportive psychotherapy. Psychother Psychosom 61: 132-142
13. Freyberger HJ, Grabe HJ, Maier W, Janca A, Stoll KD (1998) Opipramol (Insidon) in der Therapie somatoformer Störungen. Fortschr Neurol Psychiat 66, Sonderheft 1: 25-30
14. Gunderson J (1994) Personality disorders. In: American Psychiatric Assoziation DSM-IV Sourcebook, Vol 2, Washington DC, pp 647-664
15. Hill AB (1977) A short textbook of medical statistics. Hodder and Stoughton, London
16. Hiller W, Rief W, Fichter MM (1995) Further evidence for a broader concept of somatization disorder using the Somatic Symptom Index. Psychosomatics 36: 285-294
17. Hiller W, Rief W, Fichter MM (1997) How disabled are patients with somatoform disorders? General Hospital Psychiatry 19: 432-438
18. Hiller W, Rief W (1998) Therapiestudien zur Behandlung von Patienten mit somatoformen Störungen: Ein Literaturüberblick. Verhaltenstherapie 8: 125-136
19. Isaac M, Tacchini G, Janca A (1994) Screener for Somatoform Disorders. World Health Organisation, Geneva
20. Janca A, Isaac M (1997) ICD-10 and DSM-IV symptoms of somatoform disorders in different cultures. Keio J Med 46: 128-131
21. Johnston FN, Johnson S (1977) Clinical trials. Blackwell, Oxford
22. Kapfhammer HP (1996) In: Dott, Merk, Neuser, Osieka (Hrsg) Lehrbuch der Umweltmedizin: Psychiatrische Aspekte der Umweltmedizin - Zur Diagnostik und Behandlung von Umweltängsten und somatoformen Umweltunverträglichkeiten
23. Kleinmann A (1980) Patients and healers in the context of culture: an exploration of the borderland between anthropology, medicine,and psychiatry. Berkeley Press
24. Kleinschmidt S, Müßigbrot H, Schürmann A, Freyberger HJ, Dilling H (1995) Psychiatrische Diagnostik in der Allgemeinmedizin, die ICD-10 Primary Health Care. Fortschr Neurol Psychiat 63: 227-231
25. Kroenke KL et al. (1997) Multisomatoform Disorder. Arch Gen Psychiatry 54: 352-358
26. Lambrecht F (1996) Die ökonomischen Folgen von Fehlbehandlungen psychosomatischer und somato-physischer Erkrankungen. Psychother Psychosom Med Psychol 46: 283-291
27. Lichtermann D (1994) Prävalenzen von Persönlichkeitsstörungen nach DSM-III Kriterien in der Allgmeinbevölkerung und ihre Comorbidität mit Störungen der Achse I. Inauguraldissertation. Fachbereich Medizin. Johannes Gutenberg-Universität Mainz
28. Linden M, Maier W, Achberger M, Herr R, Helmchen H, Benkert O (1996) Psychische Erkrankungen in Deutschland - Ergebnisse einer Studie der Weltgesundheitsorganisation. Nervenarzt 67: 205-215
29. Malchow CP, Kanitz RD, Dilling H (1995) ICD-10 Computer-Tutorial: Psychische Störungen. Huber, pp 36-37
30. Maier W (1998) Angst und Somatisierungsstörungen: Die Diagnostik, Epidemiologie, biologischen Ursachen und therapie. Fortschr Neurol Psychiat 66, Sonderheft 1: 3-8
31. Maier W, Falkai P (1999) The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases. International Clinical Psychopharmacology 14 [Suppl 2]: 1-6
32. Oldham JM, Skodol AE, Kellmann HD, Hyler SE, Doidge N, Rosnick L, Gallher PE (1995) Comorbidity of axis I and axis II disorders. Am J Psychiatry 152: 571-578
33. Porteggijs PJM, Van der Horst FG, Proot IM, Kran KF, Gunther NCHF, Knottnerus JA (1996) Somatization in frequent attenders of general practise. Soc Psychiatry Psychiatr Epidemiol 31: 29-37
34. Robins L, Wing J, Wittchen HU et al. (1988) The Composite International Diagnostic Interview. Arch Gen Psychiatry 45: 1069-1076
35. Rost K, Kashner TM, Smith GR (1994) Effectiveness of psychiatric intervention with somatization disorder patients: improved outcome at reduced costs. Gen Hosp Psychiatry 16: 381-387
36. Sachs L (1989) Statistische Methoden; Planung und Auswertung. Springer, Berlin
37. Sharpe M, Bass C, Mayou R (1995) An overview of the treatment of functional somatic symptoms. In Mayou R, Bass C, Sharpe M (eds) Treatment of functional somatic symptoms. Oxford Univ Press, pp 66-86
38. Simon GE, Gureje O (1999) Stability of Somatization Disorder and Somatization Symptoms Among Primary Care Patients. Arch Gen Psychiatry 56: 90-95
39. Spitzer C, Freyberger HJ, Kömpf D, Kessler Ch (1994) Psychiatrische Komorbidität dissoziativer Störungen in der Neurologie. Nervenarzt 65: 680-688
40. Swarts M, Hughes D, George L, Blazer GD, Landermann R, Bucholz K (1986) Developing a screening index for community studies of somatization disorder. J Psychiatry Res 4: 335-345
41. Tölle R (1999) Funktionelle Beschwerden - Somatisierungsstörungen. Dtsch Ärztebl 96: 100-102
42. Tress W, Kruse J, Heckratth C, Schmitz N, Alberti L (1997) Der psychosomatische Patient beim Hausarzt - Ergebnisse einer Felduntersuchung. In Franz M, Tress W (Hrsg) Psychosomatische Medizin - Ankunft in der Praxis. VAS, Frankfurt, pp 55-67
43. Weiffenbach O, Gänsicke M (1998) Psychische Störungen in der Allgemeinarztpraxis: Ergebnisse einer WHO Studie. Bay Int 18: 389-393